The coronavirus pandemic caused global devastation with over 2 million deaths and put unprecedented pressure on health care facilities world-wide. The response to the pandemic differed globally as countries faced different challenges. Within Gynaecological oncology, a multitude of guidance was published by various countries and organisations which demonstrated major themes. These consisted of implementations aimed at reducing transmission, managing limited resources, treatment prioritisation whilst continuing urgent oncological surgery where possible and the use of alternative therapies in the management of oncology patients to reduce hospital admission. Due to the novelty of this virus and its global effects, published guidance is currently limited to best practice and small-scale trials. This review aims to summarise the global response to coronavirus with respect to Gynaecological oncology and suggests potential interventions to limit the spread of the virus during resurgence or in the event of a future global pandemic. It also discusses the current trials recruiting relevant to the field of Gynaecological oncology to better inform the specialty on the management of cancer patients during COVID-19.

冠状病毒大流行造成全球破坏，造成超过 200 万人死亡，给世界各地的医疗机构带来了前所未有的压力。由于各国面临不同的挑战，全球对这一流行病的反应也各不相同。在妇科肿瘤学领域，不同国家和组织发布了许多展示主要主题的指南。这些措施包括旨在减少传播、管理有限资源、确定治疗优先顺序、同时尽可能继续进行紧急肿瘤手术以及在肿瘤患者管理中使用替代疗法以减少入院率。由于这种病毒的新颖性及其全球影响，目前发布的指南仅限于最佳实践和小规模试验。本综述旨在总结全球在妇科肿瘤方面对冠状病毒的反应，并提出潜在的干预措施，以限制病毒在复发期间或未来全球大流行时的传播。它还讨论了当前与妇科肿瘤学领域相关的招募试验，以更好地为该专业提供有关 COVID-19 期间癌症患者管理的信息。